At a glance
ClinicalIndex Comparison RecordN/ACompleted· 94 enrolled
Drug / intervention
Lactobacillus casei rhamnosus Lcr35 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Lactobacillus Casei Rhamnosus Lcr35 in the Management of Children With Functional Constipation: a Randomized, Double-blind, Placebo- Controlled Trial.
In Brief
A clinical study evaluating Lactobacillus casei rhamnosus Lcr35 and Placebo for Constipation. Completed, enrolled 94 participants across 1 site.
Detailed Summary
The aim of this study is to assess the effectiveness of Lactobacillus casei rhamnosus Lcr35 administration for the treatment of functional constipation in children.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConstipation
CountriesPoland
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartNov 2013
First PostedNov 2013
Primary CompletionNov 2016
TodayJul 2026
First PostedNov 15, 2013
Enrollment StartNov 1, 2013
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 12.6 years ago
Interventions
Lactobacillus casei rhamnosus Lcr35dietary
Eligible children will receive Lactobacillus casei rhamnosus Lcr35 (8×10\^8 CFU, twice daily, orally for 4 weeks)
Placebodietary
Eligible children will receive placebo (maltodextrin), twice daily, orally for 4 weeks